The Report Guru

  The Microbiome Sequencing Services Market Share is projected to rise from USD 284 million in 2023 to USD 555 million by 2028, with a CAGR of 14.3%. This growth is driven by the growing demand for metagenomic sequencing, increased usage of sequencing technologies in human microbiome therapeutic development, and the high expenses linked to advanced sequencing equipment, leading to more outsourcing of these services. Nonetheless, the market's expansion may be hindered by a lack of skilled professionals for complex sample analysis. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=94324380 Based on service, the microbiome sequencing services industry is segmented into sample preparation, sequencing and library preparation, and data analysis services. A majority of the service providers/key market players offer all three types of services as part of the microbiome analysis workflow. Variations in sample size, associated pricing, use of different te

The global laboratory information systems market size is projected to reach USD 4.0 billion by 2028, from USD 2.4 billion in 2023, at a CAGR of 10.8% from 2023 to 2028. The growth of this market is influenced primarily due to the increasing adoption of LIS in biobanks and biorepositories, as well as the development of integrated LIS and the need to curtail escalating healthcare costs. However, high maintenance and service costs are expected to restrain the market growth during the forecast period. Download PDF Brochure:  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=232312738 The laboratory information systems (LIS) industry is witnessing several key trends that are shaping its development and future trajectory. There is a growing emphasis on interoperability and integration of LIS with other healthcare systems. Many LIS systems now offer mobile applications, allowing laboratory staff to access patient data, test results, and other information on their smartphon

The preclinical imaging market is poised for significant growth in the coming years. According to the report “Preclinical Imaging Market size by Product Type (Optical Imaging, PET, SPECT, Optical Imaging Reagents, Contrast Agents, Nuclear Imaging Reagents), Application (Oncology, Neurology), End User (Pharmaceutical, Imaging Centers) – Global Forecast to 2029,” the market is expected to reach USD 1,259 million by 2029 from USD 946 million in 2024, at a CAGR of 5.9%. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=841 Market Dynamics and Growth Drivers The preclinical imaging market is driven by several factors. Increasing funding for preclinical research is a primary catalyst, alongside the development of cost-effective imaging systems. The rising demand for new drug development and noninvasive small-animal imaging techniques also significantly boosts the market. These factors collectively drive advancements and the adoption of preclinical